查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1609987

胃肠道治疗药物市场规模、份额和趋势分析报告：2025-2030年按类型、年龄层、分销管道、地区和细分市场预测

Digestive & Intestinal Remedies Market Size, Share & Trends Analysis Report By Type (Digestive Medicines), By Age Group (Adult & Geriatric, Pediatric), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格

胃肠道和肠道治疗市场的成长和趋势

根据 Grand View Research, Inc. 的最新报告，预计 2025 年至 2030 年全球胃肠道治疗市场将以 4.25% 的复合年增长率增长，到 2030 年将达到 275.4 亿美元。消化药物是人们购买的最常见的非处方药。此外，医生建议仅在出现轻微健康问题（例如胃酸过多或使用其他消化药物）后才使用这些药物。然而，在一些国家，根据该国的规则和规定，这些药物无需处方即可直接出售给患者。

该市场主要是由对 zientac 和 omez 等商用产品的高需求所推动的。人群中胃肠道疾病的病例正在增加。此外，发炎性肠道疾病肠道疾病、便秘、大肠激躁症、胃食道逆流症等病例的增加也是预测期内推动市场成长的因素。

市场成长是由速食店和餐饮业的发展和扩张所推动的。饭店、餐厅和垃圾食品店的扩张导致油腻、辛辣和不卫生食品的消费急剧增加。此外，可支配收入的增加和忙碌的生活方式正在推动外出用餐的趋势。这导致了严重的消化器官系统和肠道问题，例​​如胃酸过多、胃部不适和炎症，从而导致消化器官系统和肠道治疗的消耗增加。

在 COVID-19 大流行期间，全球胃肠道和肠道药物的销售量下降。为遏制 COVID-19 传播而采取的封锁措施和改善卫生条件已阻止了季节性疾病的传播，导致非处方药销售下降。各製药公司纷纷发布季度财报，胃肠道和肠道治疗药物的下滑影响了市场的销售。

由于健康问题日益严重导致需求增加，胃肠道治疗药物在 2021 年占据了最大的销售份额，超过 50%。人口老化的加剧也是推动该细分市场成长的关键因素。此外，生活方式和饮食习惯的改变也增加了对胃肠治疗的需求。因此，由于这些原因，预计该细分市场在估计期间将呈现成长。

2021年，线下细分市场占据主导地位，份额高达70%以上。由于线下商店比任何其他管道更具永续性，消费者对胃肠道药物的需求不断增加。因此，预计该细分市场在评估期内将呈现成长。

由于该地区胃肠道疾病的增加，北美地区占据了市场主导地位，2021 年约占 45% 的收益占有率。此外，该地区老年人和肥胖人口的增加正在推动市场成长。其他市场发展因素包括研发活动的活性化以及主要市场参与企业的出现。

胃肠/肠道治疗市场报告亮点

  • 由于胃肠道疾病盛行率不断上升，对胃肠道和肠道治疗的需求不断增长，预计亚太地区胃肠道和肠道治疗市场将成为全球成长最快的市场。
  • 2024年，胃肠道药物占据最大的销售份额，超过51.98%，因为健康问题日益严重，对这些药物的需求增加。
  • 由于销量增加，市场细分占据了市场主导地位，2024 年份额最高为 4.11%。
  • 由于胃肠道疾病治疗的研究和开发不断增加，预计胃肠道疾病治疗领域在预测期内将出现显着的市场成长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章胃肠/肠道治疗市场的变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 胃肠道治疗市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章消化和肠道治疗市场：按类型估计和趋势分析

  • 全球胃肠道和肠道治疗市场：类型细分仪表板
  • 全球胃肠道和肠道治疗市场：类型变异分析
  • 按类型分類的收益
  • 消化药
  • 胃肠道疾病治疗药
  • 天然和合成药物

第五章消化和肠道治疗市场：按年龄组别分類的估计和趋势分析

  • 全球胃肠道和肠道治疗市场：年龄组细分仪表板
  • 全球胃肠/肠道治疗药物市场：年龄组波动分析
  • 按年龄组别分類的收益
  • 成人和老年人
  • 儿科的

第六章胃肠/肠道治疗市场：按分销管道估算和趋势分析

  • 全球胃肠道和肠道治疗市场：分销管道细分仪表板
  • 全球胃肠道治疗市场：分销管道波动分析
  • 按分销管道分類的收益
  • 离线
  • 在线的

第七章胃肠道和肠道治疗药物市场：产品、应用、最终用途、地区、估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 2024年主要企业市场占有率分析
    • Bayer AG
    • Johnson & Johnson Services Inc.
    • GSK plc.
    • Procter &Gamble
    • Sanofi
    • Boehringer Ingelheim GmbH
    • Reckitt Benckiser Group PLC
    • Abbott
    • Takeda Pharmaceutical Company Limited
    • Menarini Group
Product Code: GVR-4-68039-931-1

Digestive & Intestinal Remedies Market Growth & Trends:

The global digestive & intestinal remedies market size is estimated to reach USD 27.54 billion by 2030, expanding at a CAGR of 4.25% from 2025 to 2030, according to a new report by Grand View Research, Inc. Digestive medicines are the most common over the counter medicines purchased by people. Moreover, physicians recommend the use of these medicines only after minor health issues such as acidity and other digestive problems. But in several countries, these medicines are sold directly to the patients without prescription as per their rules and regulations.

The market is majorly driven by high demand for over-the-counter products such as zientac, omez, and others. There is an increase in gastrointestinal disorders cases among people. Moreover, increasing cases of inflammatory bowel disease, constipation, irritable bowel syndrome, and gastroesophageal reflux illness are other factors that in turn are boosting market growth over the forecast period.

The market growth is driven by the developments and expansion of fast-food joints and the food service industry. Due to the expansion of hotels, restaurants, and junk food places across the world, consumption of oily, spicy, and unhygienic food has increased extremely. Moreover, increasing disposable income and a hectic lifestyle are facilitating the trend of eating out. This significantly leads to digestive and intestinal problems such as acidity, upset stomach, inflammations, etc., and increases consumption of digestive and intestinal remedies.

During the COVID-19 pandemic, the sales of digestive and intestinal remedies were reduced globally. Lockdown measures to control the spread of COVID-19 and better hygiene have frozen the spread of seasonal illnesses, which has reduced the sales of over-the-counter medicines. Various pharmaceutical companies have displayed quarterly earnings reports which showed that a decrease in digestive and intestinal remedies has affected their bottom line sales in the market.

The digestive medicines accounted for the largest revenue share of over 50% in 2021 owing to the increasing demand for these drugs due to rising health issues. The rising aging population is also another key factor driving the segment growth. Moreover, altering lifestyles and diets has also increased the demand for digestive remedies products. Hence, owing to these reasons the segment is estimated to show growth over the estimated period.

The offline segment dominated the market with the highest share of over 70% in 2021. The demand for digestives & intestinal remedies is rising among customers due to more sustainability offered by these offline stores than any other channel. Hence the segment is projected to show growth during the assessment period.

North America dominated the market and accounted for around 45% revenue share in 2021 due to the growing number of gastrointestinal diseases in this region. Also, the growing geriatric and obese population in this region is driving the market growth. Increasing research and development activities along with the presence of key market players are other factors boosting market growth over the forecast period.

Digestive & Intestinal Remedies Market Report Highlights:

  • Asia Pacific digestive & intestinal remedies market is expected to experience the fastest growth globally owing to rising demand for digestives & intestinal remedies due to the increasing prevalence of GI illness disease
  • The digestive medicines accounted for the largest revenue share of over 51.98% in 2024 owing to the increasing demand for these drugs due to rising health issues
  • The offline segment dominated the market with the highest share of 4.11% in 2024 owing to its increasing sales
  • The remedies against gastrointestinal complaints segment is expected to register significant market growth during the forecast period owing to growing research and development in remedies against gastrointestinal complaints.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Age group
    • 1.2.3. Distribution channel
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product and age group outlook
    • 2.2.2. Distribution channel outlook
  • 2.3. Competitive Insights

Chapter 3. Digestive & Intestinal Remedies Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising incidence of digestive disorders
      • 3.2.1.2. Rising awareness about disease
      • 3.2.1.3. Technological advancement
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulations pertaining to drug approval
      • 3.2.2.2. Market saturation and high competition
  • 3.3. Digestive & Intestinal Remedies Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Digestive & Intestinal Remedies Market: Type Estimates & Trend Analysis

  • 4.1. Global Digestive & Intestinal Remedies Market: Type Segment Dashboard
  • 4.2. Global Digestive & Intestinal Remedies Market: Type Movement Analysis
  • 4.3. Global Digestive & Intestinal Remedies Market Estimates and Forecasts, By Type, Revenue (USD Million)
  • 4.4. Digestive Medicines
    • 4.4.1. Digestive medicines market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Remedies Against Gastrointestinal Complaints
    • 4.5.1. Remedies against gastrointestinal complaints market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Natural and Synthetic Agents
    • 4.6.1. Natural and synthetic agents market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Digestive & Intestinal Remedies Market: Age Group Estimates & Trend Analysis

  • 5.1. Global Digestive & Intestinal Remedies Market: Age Group Segment Dashboard
  • 5.2. Global Digestive & Intestinal Remedies Market: Age Group Movement Analysis
  • 5.3. Global Digestive & Intestinal Remedies Market Estimates and Forecasts, By Age Group, Revenue (USD Million)
  • 5.4. Adult & Geriatric
    • 5.4.1. Adult & geriatric market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Pediatric
    • 5.5.1. Pediatric market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Digestive & Intestinal Remedies Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Global Digestive & Intestinal Remedies Market: Distribution Channel Segment Dashboard
  • 6.2. Global Digestive & Intestinal Remedies Market: Distribution Channel Movement Analysis
  • 6.3. Global Digestive & Intestinal Remedies Market Estimates and Forecasts, by Distribution Channel, Revenue (USD Million)
  • 6.4. Offline
    • 6.4.1. Offline market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Online
    • 6.5.1. Online market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Digestive & Intestinal Remedies Market: Regional Estimates & Trend Analysis By Product, Application, and End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key company market share analysis, 2024
    • 8.3.2. Bayer AG
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Johnson & Johnson Services Inc.
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. GSK plc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Procter & Gamble
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Sanofi
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Boehringer Ingelheim GmbH
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Reckitt Benckiser Group PLC
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Abbott
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Takeda Pharmaceutical Company Limited
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Menarini Group
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America digestive & intestinal remedies market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 5 North America digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 6 U.S. digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 7 U.S. digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 8 U.S. digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 9 Canada digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 10 Canada digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 11 Canada digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 12 Mexico digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 13 Mexico digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 14 Mexico digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 15 Europe digestive & intestinal remedies market, by region, 2018 - 2030 (USD Million)
  • Table 16 Europe digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 17 Europe digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 18 Europe digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 19 Germany digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 20 Germany digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 21 Germany digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 22 UK digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 23 UK digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 24 UK digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 25 France digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 26 France digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 27 France digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 28 Italy digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 29 Italy digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 30 Italy digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 31 Spain digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 32 Spain digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 33 Spain digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 34 Denmark digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 35 Denmark digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 36 Denmark digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 37 Sweden digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 38 Sweden digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 39 Norway digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 40 Norway digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 41 Norway digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific digestive & intestinal remedies market, by region, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 45 Aisa Pacific digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 46 China digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 47 China digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 48 China digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 49 Japan digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 50 Japan digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 51 Japan digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 52 India digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 53 India digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 54 India digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 55 South Korea digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 56 South Korea digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 57 South Korea digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 58 Australia digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 59 Australia digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 60 Australia digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 61 Thailand digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 62 Thailand digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 63 Thailand digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 64 Latin America digestive & intestinal remedies market, by region, 2018 - 2030 (USD Million)
  • Table 65 Latin America digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 66 Latin America digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 67 Latin America digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 68 Brazil digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 69 Brazil digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 70 Brazil digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 71 Argentina digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 72 Argentina digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 73 Argentina digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 74 MEA digestive & intestinal remedies market, by region, 2018 - 2030 (USD Million)
  • Table 75 MEA digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 76 MEA digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 77 MEA digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 78 South Africa digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 79 South Africa digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 80 South Africa digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 84 UAE digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 85 UAE digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 86 UAE digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 87 Kuwait digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
  • Table 88 Kuwait digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
  • Table 89 Kuwait digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Digestive & intestinal remedies market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Digestive & intestinal remedies market segment snapshot
  • Fig. 10 Digestive & intestinal remedies market competitive snapshot
  • Fig. 11 Digestive & intestinal remedies market driver impact
  • Fig. 12 Digestive & intestinal remedies market restraint impact
  • Fig. 13 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 Value chain analysis
  • Fig. 16 Digestive & intestinal remedies market: Type outlook and key takeaways
  • Fig. 17 Digestive & intestinal remedies market: Type movement analysis
  • Fig. 18 Digestive medicines market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Remedies against gastrointestinal complaints market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Natural and synthetic agents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Digestive & Intestinal Remedies market: Age Group outlook and key takeaways
  • Fig. 22 Digestive & Intestinal Remedies market: Age Group movement analysis
  • Fig. 23 Adult & geriatric market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Pediatric market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Digestive & intestinal remedies market: Distribution channel outlook and key takeaways
  • Fig. 26 Digestive & intestinal remedies market: Distribution channel movement analysis
  • Fig. 27 Offline market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Online market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Global digestive & intestinal remedies market: Regional movement analysis
  • Fig. 30 Global digestive & intestinal remedies market: Regional outlook and key takeaways
  • Fig. 31 Global digestive & intestinal remedies market share and leading players
  • Fig. 32 North America, by country
  • Fig. 33 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. key country dynamics
  • Fig. 35 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Canada key country dynamics
  • Fig. 37 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Mexico key country dynamics
  • Fig. 39 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 UK key country dynamics
  • Fig. 42 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Germany key country dynamics
  • Fig. 44 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 France key country dynamics
  • Fig. 46 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Italy key country dynamics
  • Fig. 48 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Spain key country dynamics
  • Fig. 50 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Denmark key country dynamics
  • Fig. 52 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Sweden key country dynamics
  • Fig. 54 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Norway key country dynamics
  • Fig. 56 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 China key country dynamics
  • Fig. 59 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Japan key country dynamics
  • Fig. 61 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 India key country dynamics
  • Fig. 63 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Thailand key country dynamics
  • Fig. 65 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 South Korea key country dynamics
  • Fig. 67 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Australia key country dynamics
  • Fig. 69 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Brazil key country dynamics
  • Fig. 72 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Argentina key country dynamics
  • Fig. 74 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 South Africa key country dynamics
  • Fig. 77 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Saudi Arabia key country dynamics
  • Fig. 79 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 UAE key country dynamics
  • Fig. 81 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Kuwait key country dynamics
  • Fig. 83 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Market share Analysis of key market players, 2024